SPRING PHARMACEUTICAL GROUP, INC.

company.status.inactive

CIK 847464fmd_0W4DH9FR3FN72PMGS6V3YD2Y7CManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Apr 01, 2009 to Dec 31, 2018, 37 periods

Income Statement · Annual · Millions · USD
Line item	FY2010	FY2011	FY2012	FY2013	FY2014	FY2015	FY2016	FY2017	FY2018
Total revenues	32	33	38	33	34	38	48	56	65
Cost of revenue	14	16	17	16	16	19	27	33	40
Gross profit	18	17	20	17	18	19	21	23	25
Research and development	0	0	1	2	1	1	1	1	0
Total operating expenses	5	4	10	8	7	8	10	10	11
Operating income	13	14	10	9	11	12	11	13	15
Interest and investment income	–	–	(37)	8	(0)	0	0	0	–
Other non-operating income (expense)	0	0	(37)	–	–	–	–	–	–
Income before taxes	13	14	(27)	18	11	12	11	13	16
Income tax expense	3	3	3	2	(3)	(3)	3	3	4
Net income from continuing operations	9	10	(30)	15	13	15	8	10	12
Net income	9	10	(30)	15	8	9	8	10	12
Net income to common shareholders	–	–	–	–	–	–	–	10	11